Information Journal Paper
APA:
Copy. (2017). Effective activated PI3Kδ syndrome-targeted therapy with the PI3Kδ inhibitor leniolisib. BLOOD, 130(21), 2307-2316. SID. https://sid.ir/paper/754761/en
Vancouver:
Copy. Effective activated PI3Kδ syndrome-targeted therapy with the PI3Kδ inhibitor leniolisib. BLOOD[Internet]. 2017;130(21):2307-2316. Available from: https://sid.ir/paper/754761/en
IEEE:
Copy, “Effective activated PI3Kδ syndrome-targeted therapy with the PI3Kδ inhibitor leniolisib,” BLOOD, vol. 130, no. 21, pp. 2307–2316, 2017, [Online]. Available: https://sid.ir/paper/754761/en